RESLIZUMAB

688 reported adverse events

Drug classes: Interleukin-5 Antagonist [EPC]

These side effects are most commonly reported by patients taking RESLIZUMAB:

# Side effect Count
0 DYSPNOEA 96
1 ASTHMA 95
2 INCORRECT DOSE ADMINISTERED 88
3 DRUG INEFFECTIVE 83
4 HYPERTENSION 73
5 COUGH 47
6 HEADACHE 43
7 WHEEZING 40
8 FATIGUE 39
9 PNEUMONIA 33
See all common reactions for RESLIZUMAB

RESLIZUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INSTILLATION SITE COMPLICATION 1 0.0476
1 BRONCHOPLASTY 1 0.0417
2 NON-SMALL CELL LUNG CANCER STAGE IIIA 1 0.0357
3 CATECHOLAMINE CRISIS 1 0.0270
4 EXERCISE TOLERANCE INCREASED 1 0.0233
5 EOSINOPENIA 3 0.0227
6 ATYPICAL MIGRAINE 1 0.0217
7 RECTAL PROLAPSE REPAIR 1 0.0189
8 ADRENAL SUPPRESSION 12 0.0142
9 CHRONIC RHINOSINUSITIS WITH NASAL POLYPS 2 0.0135
See all enriched reactions for RESLIZUMAB